journal article·2007-08

Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives

Takami Akagi, Xin Wang, Tomofumi Uto, Masanori Baba, Mitsuru Akashi

Biomaterials· Volume 28· Issue 23
Publisher page

Abstract

Induction of an adaptive immune response by vaccination is possible for a broad range of infectious diseases or cancers. Antigen-loaded polymeric nanoparticles have recently been shown to possess significant potential as vaccine delivery systems and adjuvants. Here we demonstrate the use of nanoparticles composed of amphiphilic poly(amino acid) derivatives as vaccine adjuvants. We prepared protein-loaded, biodegradable nanoparticles composed of hydrophobically modified poly(gamma-glutamic acid) (gamma-PGA). gamma-PGA hydrophobic derivatives (gamma-hPGA) formed 200 nm-sized nanoparticles in water. The protein-encapsulated gamma-hPGA nanoparticles were efficiently taken up by immature dendritic cells (iDCs). Interestingly, the nanoparticle uptake by iDCs induced DC maturation. The immunization with human immunodeficiency virus (HIV)-1 gp120-encapsulated nanoparticles strongly induced antigen-specific cellular immunity. These results suggest that antigen-loaded gamma-hPGA nanoparticles provide a novel delivery tool for vaccination against viral infections or tumors. This system has potential application as a universal delivery system for protein-based vaccines capable of inducing cytotoxic T lymphocyte (CTL).
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Immunotherapy and Immune Responses · RNA Interference and Gene Delivery · Biopolymer Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (46)

Show source-provided references
1. Engineered nanoparticles as precise drug delivery systems10.1002/jcb.20796 ↗
2. Biodegradable nanoparticles for drug and gene delivery to cells and tissue10.1016/S0169-409X(02)00228-4 ↗
3. DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells10.1016/j.addr.2004.09.010 ↗
4. Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity10.1016/S0264-410X(96)00099-0 ↗
5. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules10.4049/jimmunol.153.11.4925 ↗
6. Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imaging10.1016/j.jconrel.2005.10.018 ↗
7. Dendritic cells and the control of immunity10.1038/32588 ↗
8. Vaccines that facilitate antigen entry into dendritic cells10.1111/j.0818-9641.2004.01271.x ↗
9. Characterization of poly(d,l-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells10.1016/j.vaccine.2003.12.032 ↗
10. Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?10.1016/S0168-3659(01)00412-6 ↗
11. Analysis of poly(d,l-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro10.1023/A:1020452531828 ↗
12. Liposomal delivery of antigen to human dendritic cells10.1016/S0264-410X(02)00536-4 ↗
13. Nanosphere induced gene expression in human dendritic cells10.1021/nl050541s ↗
14. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens10.1016/j.addr.2004.09.003 ↗
15. The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles10.1016/j.biomaterials.2006.10.034 ↗
16. Protein instability in poly(lactic-co-glycolic acid) microparticles10.1023/A:1026498209874 ↗
17. Formulation aspects of biodegradable polymeric microspheres for antigen delivery10.1016/j.addr.2004.09.002 ↗
18. Ion-induced morphological changes in “crew-cut” aggregates of amphiphilic block copolymers10.1126/science.272.5269.1777 ↗
19. The production of poly-(gamma-glutamic acid) from microorganisms and its various applications10.1016/S0960-8524(01)00074-8 ↗
20. Multivalent conjugates of poly-gamma-d-glutamic acid from Bacillus licheniformis with antibody F(ab′) and glycopeptide ligands10.1021/bc020019m ↗
21. Microbial degradation of poly(amino acid)s10.1021/bm049949u ↗
22. Hydrolytic and enzymatic degradation of nanoparticles based on amphiphilic poly(γ-glutamic acid)-graft-l-phenylalanine copolymers10.1021/bm050657i ↗
23. Evaluation of pH-dependent membrane-disruptive properties of poly(acrylic acid) derived polymers10.1016/S0939-6411(03)00093-6 ↗
24. On the role of methacrylic acid copolymers in the intracellular delivery of antisense oligonucleotides10.1016/j.ejpb.2005.10.010 ↗
25. Stably-dispersed and surface-functional bionanoparticles prepared by self-assembling amphipathic polymers of hydrophilic poly(γ-glutamic acid) bearing hydrophobic amino acids10.1246/cl.2004.398 ↗
26. Self-assembled soft nanofibrils of amphipathic polypeptides and their morphological transformation10.1021/cm048196f ↗
27. In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(γ-glutamic acid)10.1002/mabi.200500036 ↗
28. Preparation and characterization of biodegradable nanoparticles based on poly(γ-glutamic acid) with l-phenylalanine as a protein carrier10.1016/j.jconrel.2005.08.003 ↗
29. Multifunctional conjugation of proteins on/into bio-nanoparticles prepared by amphiphilic poly(γ-glutamic acid)10.1163/156856206777996871 ↗
30. Potent activation of antigen-specific T cells by antigen-loaded nanospheres10.1016/j.imlet.2004.10.028 ↗
31. Induction of dendritic cell-mediated immune responses against HIV-1 by antigen-capturing nanospheres in mice10.1002/jmv.20317 ↗
32. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model10.1016/j.ijpharm.2005.03.035 ↗
33. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells10.1038/79758 ↗
34. Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells10.1002/jbm.a.30131 ↗
35. Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells10.1023/B:PHAM.0000033012.16152.5d ↗
36. Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles10.1016/j.jconrel.2005.02.027 ↗
37. Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro10.1016/S0264-410X(02)00531-5 ↗
38. Encapsulation of proteins and peptides into biodegradable poly(d,l-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells10.1016/j.vaccine.2005.10.032 ↗
39. HIV-1-specific cellular immune responses among HIV-1-resistant sex workers10.1046/j.1440-1711.2000.00944.x ↗
40. Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees10.1073/pnas.86.12.4710 ↗
41. V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 110.1073/pnas.90.24.11518 ↗
42. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles10.1111/j.1365-2567.2005.02268.x ↗
43. Importance of hydrophobic region in amphiphilic structures of α-helical peptides for their gene transfer-ability into cells10.1006/bbrc.1998.8408 ↗
44. Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages10.1023/A:1022271020390 ↗
45. Transfection activity of polyamidoamine dendrimers having hydrophobic amino acid residues in the periphery10.1021/bc049785e ↗
46. Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery10.1096/fj.02-0088com ↗